Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Savage

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Cancer Research|February 15, 2019
ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGAAlan R Gilmore, Matthew Alderdice, Kienan I Savage, et al.
Cancer Research|April 15, 2015
Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATMNuala McCabe, Conor Hanna, Steven M Walker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 5, 2020
Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)Ahmet M Ulusan, Praveen Rajendran, Wan Mohaiza Dashwood, et al.
Molecular Cancer Research : MCR|July 31, 2024
Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis ModulationDaryl Griffin, Robbie Carson, Debbie Moss, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2022
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast CancerAbhijit Mazumdar, William M Tahaney, Jamal L Hill, et al.
Oncogene|February 26, 2013
NF-κB is a critical mediator of BRCA1-induced chemoresistanceMary T Harte, Julia J Gorski, Kienan I Savage, et al.
Quality & Safety in Health Care|October 9, 2009
Care homes' use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older peopleN D Barber, D P Alldred, D K Raynor, et al.
Breast Cancer Research : BCR|March 27, 2024
Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growthJing Qian, Yanxia Ma, William M Tahaney, et al.
Breast Cancer Research : BCR|February 5, 2024
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growthJing Qian, Yanxia Ma, William M Tahaney, et al.
The Journal of Pathology. Clinical Research|February 6, 2020
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriersAlan D McCrorie, Susannah Ashfield, Aislinn Begley, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Cancer Research|February 15, 2019
ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGAAlan R Gilmore, Matthew Alderdice, Kienan I Savage, et al.
Cancer Research|April 15, 2015
Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATMNuala McCabe, Conor Hanna, Steven M Walker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 5, 2020
Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)Ahmet M Ulusan, Praveen Rajendran, Wan Mohaiza Dashwood, et al.
Molecular Cancer Research : MCR|July 31, 2024
Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis ModulationDaryl Griffin, Robbie Carson, Debbie Moss, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2022
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast CancerAbhijit Mazumdar, William M Tahaney, Jamal L Hill, et al.
Oncogene|February 26, 2013
NF-κB is a critical mediator of BRCA1-induced chemoresistanceMary T Harte, Julia J Gorski, Kienan I Savage, et al.
Quality & Safety in Health Care|October 9, 2009
Care homes' use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older peopleN D Barber, D P Alldred, D K Raynor, et al.
Breast Cancer Research : BCR|March 27, 2024
Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growthJing Qian, Yanxia Ma, William M Tahaney, et al.
Breast Cancer Research : BCR|February 5, 2024
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growthJing Qian, Yanxia Ma, William M Tahaney, et al.
The Journal of Pathology. Clinical Research|February 6, 2020
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriersAlan D McCrorie, Susannah Ashfield, Aislinn Begley, et al.
Pageof 7